Enrico Martin

264 Chapter 11 Table 4 Functional reconstructions performed in MPNST patients. Case Sex, age YOD NF1 Size Tumor site Treatment stage Interval (days)* Reconstructions Other treatment Motor outcome Sensory outcome Clinical outcome F-U (months) 1 F, 30 2018 NF1 NA Ulnar nerve Initial treatment 0 AIN to motor ulnar and sural nerve grafts for ulnar adRTx NA NA ANOD 10 2 M, 11 2016 NF1 12.5cm Tibial nerve Initial treatment 1076 Sural nerve graft neoCTx Complete tibial nerve palsy No recovery ANOD 35 3 F, 42 2016 S 1.5cm Medial cord Initial treatment 34 ECRL to FDP II-V, BR to FPL, EIP to opponens adCTx NA NA LR, DOD 45 4 F, 10 2016 NF1 4.0cm Quadriceps muscle Recurrence NA Rotationplasty neoCTx NA NA ANOD 43 5 F, 11 2015 S 8.5cm Radial nerve Initial treatment 43 PT to ECRB, FDS III to EPL, FCR to EDC None NA NA ANOD 48 6 F, 48 2015 NF1 3.4cm Median nerve Initial treatment NA FDP II side-to-side FDP III-V, BR to FPL, EIP to opponens, RSN to UDN dig. I neoRTx NA NA DOD 22 7 M, 39 2014 S NA Ulnar nerve Recurrence NA Sural nerve graft for ulnar nerve RTx NA NA DOD 65 8 F, 19 2013 S 6.0cm Tibial nerve Initial treatment NA Sural nerve graft neoRTx, neoCTx NA NA ANOD 6 9 F, 9 2013 S 3.8cm Facial nerve Initial treatment 659 Cross-facial nerve graft with gracilis muscle transfer adRTx, adCTx Amelioration in rest and smile NA ANOD 79 10 F, 12 2011 S 3.0cm Hypoglossal nerve Initial treatment NA Nerve graft None NA NA DOD 81 11 M, 58 2011 S 4.5cm Radial nerve Initial treatment 1025 PT to ECRB, FDS IV to EPL and EIP, FDS III to EDC, FCR to APL neoRTx, adCTx Finger extension M3, wrist extension M3 No recovery LR, M, DOD 62